Postorgasmic illness syndrome benefiting from omalizumab and antidepressant: a case report
Abstract Background Postorgasmic illness syndrome is characterized by flu, rhinitis, conjunctivitis, loss of appetite, muscle weakness, and fatigue after ejaculation, lasting 2–7 days. The multidisciplinary treatment approach, incorporating omalizumab and antidepressants, has rarely been documented...
Saved in:
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2024-12-01
|
| Series: | Journal of Medical Case Reports |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s13256-024-04986-2 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|